Form S-3ASR Mersana Therapeutics,

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Form S-3ASR Mersana Therapeutics,

Mersana (MRSN) PT Raised to $15 at Citi, Opens Catalyst Watch

May 10, 2023 3:24 PM EDT

Citi analyst Ashiq Mubarack raised the price target on Mersana (NASDAQ: MRSN) to $15.00 (from $12.00) while maintaining a Buy rating.

The analys topens a 90-day upside catalyst watch commenting "In mid-2023, MRSN will share topline results from the pivotal UPLIFT Ph2 trial evaluating UpRi in... More

Mersana Therapeutics (MRSN) Files Mixed Shelf

May 9, 2023 4:15 PM EDT

Mersana Therapeutics (NASDAQ: MRSN) has filed mixed shelf of:

Common Stock
Preferred Stock
Warrants
Units

... More